National Conference on Women’s Health Research Taking Place in September

In partnership with the Society for Women’s Health Research, the Center for Women’s Health Research (CWHR) at the University of Colorado Anschutz Medical Campus is hosting a National Conference on Women’s Health Research entitled “Sex Differences Across the Lifespan: A Focus on Metabolism” from September 28 to 30.

This conference will convene some of the best minds in sex-difference research to share knowledge and ideas, while setting the stage for the next pivotal scientific research in cardiometabolic risk across the lifespan. A collaborative, productive environment will be fostered through interactive sessions, poster presentations, focus groups, and keynote speakers. Conference attendees will have strong opportunities for networking, exchanging new ideas, and creating plans for collaborative, interdisciplinary research to tackle unaddressed questions in sex-difference research.

In addition to updates from senior scientists, there will be a national call for abstracts for poster presentations. The conference will showcase the talents of the CWHR’s junior scientists who are being invited to present their work in dynamic five-minute updates. This small meeting format will further the CWHR’s mission of mentorship and collaboration across career generations.

CWHR is focused on research to prevent, treat, and cure cardiovascular and metabolic diseases in women, as well mentoring the next generation of scientists in women’s health and educating the public. The hope is that via research that addresses sex differences, future breakthroughs to improve the health of both women and men will occur.

To learn more, register, or submit a poster abstract, visit

You may also like

  • Endocrine Society Urges Congress to Increase Funding for NIH

    Funding needed by start of new fiscal year to advance public health during pandemic The Endocrine Society is calling on Congress to pass the House Labor-HHS spending bill to ensure health agencies are funded before the start of Fiscal Year 2021 and to avoid the tumult and disruption of a continuing resolution and potential government shutdowns. The…

  • Individuals Taking Class of Steroid Medications at High Risk for COVID-19

    JCEM Editors examine pandemic’s impact on endocrine patients in editorial Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according…

Find more in